Physician profile
Justin Monroe
NPI 1760592935
$13,925.72
in general payments reported to CMS, 2019-2025
14 companies · $1,377 in 2025
The $1,377 reported for 2025 was more than what 77% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $46.43 · 2021: $16.73 · 2022: $144 · 2023: $85.01 · 2024: $173 · 2025: $1,377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,121 · Food and Beverage: $515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,120.82 |
| Food and Beverage | $514.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,011.53 | 2019-2025 | |
| Ethicon US, LLC | $458.95 | 2019-2024 | Enseal, Surgiflo Hemostatic Matrix, Echelon Circular |
| Takeda Pharmaceuticals U.S.A., INC. | $81.99 | 2024 | Gattex |
| Kci USA, INC. | $48.84 | 2023 | Prevena, V.A.C.Ulta |
| Pacira Pharmaceuticals Incorporated | $46.25 | 2024-2025 | Exparel |
| Medtronic, INC. | $42.07 | 2024-2025 | Interstim, Ligasure |
| Innovation Technologies INC | $41.88 | 2025 | Irrisept |
| Biotissue Holdings INC. | $41.05 | 2025 | |
| Smith+Nephew, INC. | $29.63 | 2025 | Grafix Xc, Grafix Pl |
| Kerecis Limited | $28.21 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Reprise Biomedical, INC. | $24.43 | 2025 | Miro 3d |
| Mimedx Group, INC. | $24.25 | 2025 | |
| Convatec INC. | $23.56 | 2025 | |
| Acera Surgical, INC. | $23.08 | 2024 | Restrata Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Monroe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.